{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:28:26Z","timestamp":1790947706028,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.lanmic.2025.101211","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T23:43:34Z","timestamp":1764632614000},"page":"101211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-9069","authenticated-orcid":false,"given":"Diane","family":"Gbesemete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheshi N","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2027-3095","authenticated-orcid":false,"given":"Muktar","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison R","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3493-8895","authenticated-orcid":false,"given":"Lucy","family":"Raud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela M","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8163-7481","authenticated-orcid":false,"given":"Adam P","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay R","family":"Laver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyween","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul N","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A N","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Babbage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Weissfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Locht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Samal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Solovay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5555-9328","authenticated-orcid":false,"given":"Stephanie","family":"Noviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4297-6728","authenticated-orcid":false,"given":"Robert C","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2025.101211_bib1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMcp041025","article-title":"Clinical practice. Pertussis\u2014not just for kids","volume":"352","author":"Hewlett","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2025.101211_bib2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1473-3099(17)30390-0","article-title":"An update of the global burden of pertussis in children younger than 5 years: a modelling study","volume":"17","author":"Yeung","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101211_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp1209051","article-title":"Epidemic pertussis in 2012\u2014the resurgence of a vaccine-preventable disease","volume":"367","author":"Cherry","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2025.101211_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lanmic.2025.101211_bib5","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1016\/j.vaccine.2017.11.055","article-title":"Will we have new pertussis vaccines?","volume":"36","author":"Locht","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2025.101211_bib6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12916-015-0382-8","article-title":"Asymptomatic transmission and the resurgence of Bordetella pertussis","volume":"13","author":"Althouse","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.lanmic.2025.101211_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.7063839","article-title":"Directly transmitted infections diseases: control by vaccination","volume":"215","author":"Anderson","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.lanmic.2025.101211_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/cid\/ciz842","article-title":"Toward a controlled human infection model of pertussis","volume":"71","author":"Merkel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101211_bib9","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1371\/journal.ppat.0020065","article-title":"Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough","volume":"2","author":"Mielcarek","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.lanmic.2025.101211_bib10","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41385-018-0073-9","article-title":"IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine","volume":"11","author":"Solans","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.lanmic.2025.101211_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/infdis\/jix254","article-title":"Live attenuated pertussis vaccine BPZE1 protects baboons against Bordetella pertussis disease and infection","volume":"216","author":"Locht","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101211_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083449","article-title":"A phase I clinical study of a live attenuated Bordetella pertussis vaccine \u2013 BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers","volume":"9","author":"Thorstensson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101211_bib13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1473-3099(20)30274-7","article-title":"Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study","volume":"20","author":"Jahnmatz","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101211_bib14","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1016\/j.vaccine.2022.09.075","article-title":"Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults","volume":"40","author":"Buddy Creech","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2025.101211_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(22)02644-7","article-title":"Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial","volume":"401","author":"Keech","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2025.101211_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/cid\/ciz840","article-title":"Controlled human infection with Bordetella pertussis induces asymptomatic, immunizing colonization","volume":"71","author":"de Graaf","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101211_bib17","doi-asserted-by":"crossref","first-page":"e01301","DOI":"10.1128\/genomeA.01301-14","article-title":"Complete genome sequences of Bordetella pertussis isolates B1917 and B1920, representing two predominant global lineages","volume":"2","author":"Bart","year":"2014","journal-title":"Genome Announc"},{"key":"10.1016\/j.lanmic.2025.101211_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133209","article-title":"Correlation of real time PCR cycle threshold cut-off with Bordetella pertussis clinical severity","volume":"10","author":"Bolotin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2025.101211_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/INF.0000000000003471","article-title":"Association between real-time polymerase chain reaction cycle threshold value and clinical severity in neonates and infants infected with Bordetella pertussis","volume":"41","author":"Thuy Nga","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lanmic.2025.101211_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1574-695X.2005.00001.x","article-title":"Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies","volume":"46","author":"Rodr\u00edguez","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.lanmic.2025.101211_bib21","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.4049\/jimmunol.167.11.6545","article-title":"Fc receptor-mediated immunity against Bordetella pertussis","volume":"167","author":"Rodriguez","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.lanmic.2025.101211_bib22","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1172\/JCI135020","article-title":"Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans","volume":"130","author":"Lin","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lanmic.2025.101211_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/toxins13090623","article-title":"The history of pertussis toxin","volume":"13","author":"Locht","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.lanmic.2025.101211_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9258","article-title":"Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons","volume":"6","author":"Nguyen","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.lanmic.2025.101211_bib25","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2025.101211_bib26","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.3389\/fmicb.2020.02108","article-title":"Acellular pertussis vaccines induce anti-pertactin bactericidal antibodies which drives the emergence of pertactin-negative strains","volume":"11","author":"Lesne","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.lanmic.2025.101211_bib27","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.7.1700832","article-title":"Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015","volume":"24","author":"Barkoff","year":"2019","journal-title":"Euro Surveill"},{"key":"10.1016\/j.lanmic.2025.101211_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000506515","article-title":"Humoral first-line mucosal innate defence in vivo","volume":"12","author":"Persson","year":"2020","journal-title":"J Innate Immun"},{"key":"10.1016\/j.lanmic.2025.101211_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/vaccines8040621","article-title":"Next-generation pertussis vaccines based on the induction of protective T cells in the respiratory tract","volume":"8","author":"Chasaide","year":"2020","journal-title":"Vaccines"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:06:52Z","timestamp":1766448412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524725001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2666524725001399"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101211","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101211"}}